Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Werewolf Therapeutics Inc (HOWL)

Werewolf Therapeutics Inc (HOWL)
0.8473 +0.0175 (+2.11%) 13:27 ET [NASDAQ]
0.8473 x 5 0.8585 x 4
Realtime by (Cboe BZX)
0.8473 x 5 0.8585 x 4
Realtime 0.8712 +0.0414 (-) 08:19 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.8354
Day High
0.9150
Open 0.8557
Previous Close 0.8298 0.8298
Volume 71,657 71,657
Avg Vol 259,545 259,545
Stochastic %K 70.56% 70.56%
Weighted Alpha -84.77 -84.77
5-Day Change +0.0924 (+11.97%) +0.0924 (+11.97%)
52-Week Range 0.5950 - 6.8900 0.5950 - 6.8900
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 37,197
  • Shares Outstanding, K 44,827
  • Annual Sales, $ 1,890 K
  • Annual Income, $ -70,520 K
  • EBIT $ -66 M
  • EBITDA $ -64 M
  • 60-Month Beta 0.48
  • Price/Sales 21.85
  • Price/Cash Flow N/A
  • Price/Book 0.56
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.53
  • Most Recent Earnings $-0.46 on 03/11/25
  • Next Earnings Date 05/02/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 189.81% ( -107.36%)
  • Historical Volatility 109.91%
  • IV Percentile 54%
  • IV Rank 15.80%
  • IV High 1,118.91% on 04/10/25
  • IV Low 15.47% on 10/15/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 10
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 753
  • Open Int (30-Day) 2,150

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.44
  • Number of Estimates 3
  • High Estimate -0.43
  • Low Estimate -0.45
  • Prior Year -0.39
  • Growth Rate Est. (year over year) -12.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5950 +45.24%
on 04/07/25
Period Open: 1.1300
1.1800 -26.76%
on 03/24/25
-0.2658 (-23.52%)
since 03/21/25
3-Month
0.5950 +45.24%
on 04/07/25
Period Open: 1.3600
1.5997 -45.98%
on 02/13/25
-0.4958 (-36.46%)
since 01/22/25
52-Week
0.5950 +45.24%
on 04/07/25
Period Open: 6.0900
6.8900 -87.46%
on 04/29/24
-5.2258 (-85.81%)
since 04/22/24

Most Recent Stories

More News
Werewolf Therapeutics Appoints Steven Bloom as Chief Business Officer

HOWL : 0.8473 (+2.11%)
Werewolf Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

HOWL : 0.8473 (+2.11%)
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

HOWL : 0.8473 (+2.11%)
Werewolf Therapeutics to Present at the 2025 Leerink Partners Global Biopharma Conference

HOWL : 0.8473 (+2.11%)
Werewolf Therapeutics Appoints Anil Singhal, Ph.D., to its Board of Directors

HOWL : 0.8473 (+2.11%)
Werewolf Therapeutics Provides Business Update and Highlights 2025 Strategic Outlook

HOWL : 0.8473 (+2.11%)
Werewolf Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Healthcare Conference

HOWL : 0.8473 (+2.11%)
Werewolf Therapeutics Presents Preclinical and Clinical Data at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting

HOWL : 0.8473 (+2.11%)
Werewolf Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

HOWL : 0.8473 (+2.11%)
Werewolf Therapeutics Announces Promising New Development Candidate, WTX-921, a first-of-its-kind IL-10 INDUKINEâ„¢ Molecule for Inflammatory Diseases

HOWL : 0.8473 (+2.11%)

Business Summary

Werewolf Therapeutics Inc. is a biopharmaceutical company. It involved in the development of conditionally activated therapeutics engineered to stimulate the body's immune system for the treatment of cancer. Werewolf Therapeutics Inc. is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 0.9364
2nd Resistance Point 0.9132
1st Resistance Point 0.8715
Last Price 0.8473
1st Support Level 0.8066
2nd Support Level 0.7834
3rd Support Level 0.7417

See More

52-Week High 6.8900
Fibonacci 61.8% 4.4853
Fibonacci 50% 3.7425
Fibonacci 38.2% 2.9997
Last Price 0.8473
52-Week Low 0.5950

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro